AAIC 2025 Abstract

Anticoagulation as a Limitation to New Alzheimer's Disease Anti‐Amyloid Monoclonal Antibodies therapy

Study in peoplePopulations

Abstract

Background: Over 6 million Americans are living with Alzheimer's disease (AD). AD poses a significant public health challenge.

The paper

New York City Health and Hospitals Corporation

AAIC 2025 Abstract, 23 Dec 2025, CC BY

Presented at AAIC 2025

doi.org/10.1002/alz70860_102086